(Q51566825)

7 April 2018

review article

1 reference

title

Triglyceride as a risk factor for coronary artery disease. (English)

1 reference

7 April 2018

0 references

1 reference

A M Gotto

1

1 reference

7 April 2018

language of work or name

English

0 references

publication date

1 November 1998

1 reference

7 April 2018

American Journal of Cardiology

published in

1 reference

7 April 2018

volume

82

1 reference

7 April 2018

issue

9A

1 reference

7 April 2018

page(s)

22Q-25Q

1 reference

7 April 2018

Epidemiology as a guide to clinical decisions. The association between triglyceride and coronary heart disease

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900770-X

Epidemiology of triglycerides: a view from Framingham

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900770-X

Triglyceride concentration and ischemic heart disease: an eight-year follow-up in the Copenhagen Male Study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900770-X

Small LDL, atherogenic dyslipidemia, and the metabolic syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900770-X

Joint effects of serum triglyceride and LDL cholesterol and HDL cholesterol concentrations on coronary heart disease risk in the Helsinki Heart Study. Implications for treatment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900770-X

Relation of high-density lipoprotein cholesterol and triglycerides to incidence of atherosclerotic coronary artery disease (the PROCAM experience). Prospective Cardiovascular Münster study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900770-X

Hypertriglyceridemia and elevated lipoprotein(a) are risk factors for major coronary events in middle-aged men

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900770-X

Triglyceride- and cholesterol-rich lipoproteins have a differential effect on mild/moderate and severe lesion progression as assessed by quantitative coronary angiography in a controlled trial of lovastatin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900770-X

The role of triglyceride-rich lipoprotein families in the progression of atherosclerotic lesions as determined by sequential coronary angiography from a controlled clinical trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900770-X

The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events Trial investigators

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900770-X

Familial apolipoprotein E deficiency

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900770-X

Postprandial lipoproteins and progression of coronary atherosclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900770-X

Relation of triglyceride metabolism and coronary artery disease. Studies in the postprandial state.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900770-X

Effect of a single high-fat meal on endothelial function in healthy subjects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900770-X

Association of postprandial triglyceride and retinyl palmitate responses with asymptomatic carotid artery atherosclerosis in middle-aged men and women. The Atherosclerosis Risk in Communities (ARIC) Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900770-X

Regression of coronary artery disease as a result of intensive lipid-lowering therapy in men with high levels of apolipoprotein B

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900770-X

Efficacy and safety of a new HMG-CoA reductase inhibitor, atorvastatin, in patients with hypertriglyceridemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900770-X

Comparison of statins in hypertriglyceridemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900770-X

Effect of statins on metabolism of apo-B-containing lipoproteins in hypertriglyceridemic men.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900770-X

10.1016/S0002-9149(98)00770-X

7 January 2021

Identifiers

DOI

1 reference

7 April 2018

PubMed ID

9819100

1 reference

7 April 2018